miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy
- 947 Downloads
Neoadjuvant chemoradiation therapy has been shown to improve the outcome in patients with rectal cancer and is generally accepted as standard care; however, only selected patients would benefit from this treatment. We aimed to identify predictors of response to neoadjuvant chemoradiation therapy in colorectal cancer using formalin-fixed paraffin-embedded (FFPE) tissues as source of genetic materials and microarray analysis as investigation tool.
After optimization of RNA extraction methods from FFPE, microarray analysis was carried out on total RNA extracted from 12 pre-treatment FFPE rectal tissues using Megaplex pool A. Microarray data were analysed using an artificial neural network algorithm. Statistical analysis and correlation with clinicopathological data was performed using SPSS software.
A distinct miRNA expression signature predictive of response to neoadjuvant CRT in 12 FFPE pre-treatment rectal cancer tissue samples was identified. These signatures consisted of three miRNA transcripts (miR-16, miR-590-5p and miR-153) to predict complete vs. incomplete response and two miRNA transcript (miR-519c-3p and miR-561) to predict good vs. poor response with a median accuracy of 100 %.
Using microarray analysis of pretreatment FFPE rectal cancer tissues, we identified for the first time a group of miRNA predictors of response to neoadjuvant CRT. This, indeed, can lead to a significant improvement in patient selection criteria and personalized rectal cancer management.
KeywordsmiRNA expressions in rectal cancer Molecular profiling in rectal cancer Neoadjuvant chemoradiation therapy for rectal cancer
We would like to thank the National Breast Cancer Research Institute for their financial support of the study.
Conflict of interest
The authors declare that they have no competing interests.
- 3.Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJT, Pahlman L, Glimelius B, van Krieken J, Leer JWH, van de Velde CJH, Dutch Colorectal Canc (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638–646PubMedCrossRefGoogle Scholar
- 4.Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Canc Study (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731–1740PubMedCrossRefGoogle Scholar
- 5.Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Pefiot JF, Roussel A, Jacob JH, Segol P, Samama G, Ollivier JM, Bonvalot S, Gignoux M (1994) Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 73(11):2680–2688PubMedCrossRefGoogle Scholar
- 13.Lassmann S, Kreutz C, Schoepflin A, Hopt U, Timmer J, Werner M (2009) A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens. J Mol Med (Berlin) 87(2):211–224Google Scholar
- 19.Negrini M, Calin GA (2008) Breast cancer metastasis: a microRNA story. Breast Canc Res 10(2)Google Scholar
- 23.Bishop C (1995) Neural networks for pattern recognition. Oxford University Press, OxfordGoogle Scholar
- 25.Michael MZ, O’Connor SM, Pellekaan NGV, Young GP, James RJ (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Canc Res 1(12):882–891Google Scholar
- 28.Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang CY, Tran N, Fan HT, Retzlaff K, Bittner A, Raponi M (2009) Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 9:374Google Scholar
- 29.Slaby O, Hrstka R, Dubska L, Svoboda M, Ruckova E, Ovesna J, Vyzula R (2008) Significance of microRNA-21 in colorectal cancer pathogenesis. FEBS J 275:465–465Google Scholar
- 32.Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJW, Yang PC (2008) MicroRNA signature predicts survival and relapse in lung cancer. Canc Cell 13(1):48–57CrossRefGoogle Scholar
- 33.Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DLW, Au GKH, Liu CG, Calin GA, Croce CM, Harris CC (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. J Am Med Assoc 299(4):425–436CrossRefGoogle Scholar
- 41.Valentini V, Coco C, Picciocchi A, Morganti AG, Trodella L, Ciabattoni A, Cellini F, Barbaro B, Cogliandolo S, Nuzzo G, Doglietto GB, Ambesi-Impiombato F, Cosimelli M (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53(3):664–674PubMedCrossRefGoogle Scholar
- 48.Earle JSL, Luthra R, Romans A, Abraham R, Ensor J, Yao, Hamilton SR (2010) Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mole Diagn 12(4):433–440Google Scholar
- 49.Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Canc 126(5):1166–1176Google Scholar
- 51.Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 17(2):215–220Google Scholar